secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001615219-24-000062
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius Pharmaceuticals files prospectus supplement for $810,973 at-the-market offering
--------------------------------------------------------------------------------

- At-the-market offering of up to $810,973 of common stock via Ladenburg Thalmann & Co. Inc.
- Prospectus supplement filed July 22, 2024 under existing S-3 registration statement (File No. 333-266589).
- Legal opinion of Hogan Lovells US LLP on share validity filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521924000062/0001615219-24-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521924000062/flks-20240722.htm
  HTML page:      https://secwatch.observer/filing/0001615219-24-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer